Drug intelligence / Profile preview

simvastatin + ursodeoxycholic acid

Development stage
Unknown
Lead developer
Chang Gung Memorial Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Simvastatin + ursodeoxycholic acid is a combination therapy being evaluated in a Phase 2 clinical trial led by Chang Gung Memorial Hospital for the treatment of stable liver cirrhosis. Simvastatin is a small molecule HMG-CoA reductase inhibitor traditionally used for hypercholesterolemia, but it is being repurposed here for its pleiotropic effects, including the reduction of hepatic inflammation and fibrosis. Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid used to treat cholestatic liver diseases. The study investigates whether the combination of these two agents can synergistically improve liver function, modulate the gut-liver axis by balancing gut microbiota, and normalize bile acid metabolism in patients who have achieved viral eradication or have inactive hepatitis.

Other names
SimvastatinUrsodeoxycholic AcidUDCA
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on simvastatin + ursodeoxycholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on simvastatin + ursodeoxycholic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call